Global Zeuterin Market Research Report 2022

Zeuterin™ (also labeled as EsterilSol™ in some countries) is a non-surgical sterilant for male dogs delivered via intratesticular injection. The active ingredient is zinc gluconate neutralized with arginine. The formulation causes permanent sterility in one treatment. The process of neutering with Zeuterin/EsterilSol is also known as “zinc neutering.” Launched in the U.S. in February 2014 and suspended distribution in 2016 by Ark Sciences, LLC, Zeuterin is presently the only non-surgical sterilant with U.S. Food & Drug Administration (FDA) approval.
Due to the COVID-19 pandemic, the global Zeuterin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, the Europe Zeuterin market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Zeuterin landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In United States, Zeuterin manufacture is Ark Sciences, Inc. In terms of applications, the largest application is animal hospital with a share about 88%.
This report focuses on Zeuterin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Zeuterin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: United States., etc.
Global Zeuterin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Type I
Type II
Segment by Application
Animal Hospital
Research Institution
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Ark Sciences, Inc